Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Nov 6;43(12):1262-5.
doi: 10.1038/ng.994.

Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2

M Fernanda Amary  1 , Stephen Damato, Dina Halai, Malihe Eskandarpour, Fitim Berisha, Fiona Bonar, Stan McCarthy, Valeria R Fantin, Kimberly S Straley, Samira Lobo, Will Aston, Claire L Green, Rosemary E Gale, Roberto Tirabosco, Andrew Futreal, Peter Campbell, Nadège Presneau, Adrienne M Flanagan
Affiliations

Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2

M Fernanda Amary et al. Nat Genet. .

Abstract

Ollier disease and Maffucci syndrome are characterized by multiple central cartilaginous tumors that are accompanied by soft tissue hemangiomas in Maffucci syndrome. We show that in 37 of 40 individuals with these syndromes, at least one tumor has a mutation in isocitrate dehydrogenase 1 (IDH1) or in IDH2, 65% of which result in a R132C substitution in the protein. In 18 of 19 individuals with more than one tumor analyzed, all tumors from a given individual shared the same IDH1 mutation affecting Arg132. In 2 of 12 subjects, a low level of mutated DNA was identified in non-neoplastic tissue. The levels of the metabolite 2HG were measured in a series of central cartilaginous and vascular tumors, including samples from syndromic and nonsyndromic subjects, and these levels correlated strongly with the presence of IDH1 mutations. The findings are compatible with a model in which IDH1 or IDH2 mutations represent early post-zygotic occurrences in individuals with these syndromes.

PubMed Disclaimer

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cancer Cell. 2010 May 18;17(5):510-22 - PubMed
    1. PLoS One. 2011;6(5):e19868 - PubMed
    1. Nature. 2009 Dec 10;462(7274):739-44 - PubMed
    1. Cancer Cell. 2010 Dec 14;18(6):553-67 - PubMed
    1. J Neuropathol Exp Neurol. 2011 Aug;70(8):715-23 - PubMed

Publication types